In animal models, it has been observed that vasoactive intestinal peptide (VIP), an immunomodulatory neuropeptide released in inflammatory conditions, can generate tolDCs that can restore tolerance in vivo in trinitrobenzene sulphonic acid (TNBS)-induced colitis [167,168]. The gene discussed is VIP; the disease is colitis.